Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Chapple

Showing results (221-230 of 271) with videos related to

Pageof 28
Sort By:
BJU International|April 10, 2014
Total urgency and frequency score as a measure of urgency and frequency in overactive bladder and storage lower urinary tract symptomsChristopher R Chapple, Marcus J Drake, Philip Van Kerrebroeck, et al.
European Urology|April 22, 2008
Lower urinary tract symptoms revisited: a broader clinical perspectiveChristopher R Chapple, Alan J Wein, Paul Abrams, et al.
Therapeutic Advances in Urology|June 8, 2017
Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studiesAndrea Tubaro, José E Batista, Victor W Nitti, et al.
European Urology|June 19, 2007
Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mgChristopher R Chapple, Aino Fianu-Jonsson, Mark Indig, et al.
European Urology|August 18, 2009
A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literatureAlexander Roosen, Christopher R Chapple, Roger R Dmochowski, et al.
European Urology|November 5, 2013
Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosisNadir I Osman, Christopher R Chapple, Paul Abrams, et al.
Biomed Research International|August 20, 2014
Acute in vivo response to an alternative implant for urogynecologySabiniano Roman Regueros, Maarten Albersen, Stefano Manodoro, et al.
BJU International|January 22, 2009
Urological symptom clusters and health-related quality-of-life: results from the Boston Area Community Health SurveySusan A Hall, Carol L Link, Sharon L Tennstedt, et al.
Neurourology and Urodynamics|February 21, 2013
A proof-of-concept study: mirabegron, a new therapy for overactive bladderChristopher R Chapple, Gerard Amarenco, Miguel A López Aramburu, et al.
European Urology|July 24, 2017
Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract SymptomsGiuseppe Magistro, Christopher R Chapple, Mostafa Elhilali, et al.
Pageof 28

Showing results (221-230 of 271) with videos related to

Sort By:
Pageof 28
BJU International|April 10, 2014
Total urgency and frequency score as a measure of urgency and frequency in overactive bladder and storage lower urinary tract symptomsChristopher R Chapple, Marcus J Drake, Philip Van Kerrebroeck, et al.
European Urology|April 22, 2008
Lower urinary tract symptoms revisited: a broader clinical perspectiveChristopher R Chapple, Alan J Wein, Paul Abrams, et al.
Therapeutic Advances in Urology|June 8, 2017
Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studiesAndrea Tubaro, José E Batista, Victor W Nitti, et al.
European Urology|June 19, 2007
Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mgChristopher R Chapple, Aino Fianu-Jonsson, Mark Indig, et al.
European Urology|August 18, 2009
A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literatureAlexander Roosen, Christopher R Chapple, Roger R Dmochowski, et al.
European Urology|November 5, 2013
Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosisNadir I Osman, Christopher R Chapple, Paul Abrams, et al.
Biomed Research International|August 20, 2014
Acute in vivo response to an alternative implant for urogynecologySabiniano Roman Regueros, Maarten Albersen, Stefano Manodoro, et al.
BJU International|January 22, 2009
Urological symptom clusters and health-related quality-of-life: results from the Boston Area Community Health SurveySusan A Hall, Carol L Link, Sharon L Tennstedt, et al.
Neurourology and Urodynamics|February 21, 2013
A proof-of-concept study: mirabegron, a new therapy for overactive bladderChristopher R Chapple, Gerard Amarenco, Miguel A López Aramburu, et al.
European Urology|July 24, 2017
Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract SymptomsGiuseppe Magistro, Christopher R Chapple, Mostafa Elhilali, et al.
Pageof 28